Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Akash Bakshi currently holds 884,072 shares of NeuroBo Pharmaceuticals, Inc. (NRBO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Akash Bakshi has been a net neutral trader of NRBO stock. They have purchased $0 and sold $0 worth of shares.
Akash Bakshi's most recent insider trade was on Dec 31, 2020, when they sold 855,059 shares at $0.00 per share.
Akash Bakshi serves as Executive at NeuroBo Pharmaceuticals, Inc. (NRBO). They have executed 2 insider transactions totaling $0 over their tenure at the company.
Akash Bakshi holds the position of Executive at NeuroBo Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Akash Bakshi has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Akash Bakshi was on Dec 31, 2020, when they purchased $0 worth of NRBO shares. This transaction involved 855,059 shares at N/A per share.
Akash Bakshi currently owns 884,072 shares of NeuroBo Pharmaceuticals, Inc. (NRBO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Akash Bakshi's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Akash Bakshi has 2 Form 4 filings on record as an insider at NeuroBo Pharmaceuticals, Inc..
Set alerts for Akash Bakshi and 40,000+ other insiders.